Publication & Citation Trends
Publications
201 total
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial PDF
Cited by 735
OpenAlex
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Cited by 429
OpenAlex
Prospective Evaluation of Magnetic Resonance Imaging and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study PDF
Cited by 313
OpenAlex
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM PDF
Cited by 235
OpenAlex
Un train peut en cacher un autre : toxicité sévère au méthotrexate sur génotype hétérozygote C677 T MTHFR compliquant un syndrome hémolytique et urémique à Escherichia coli O157 :H7 (SHU-D+)
Cited by 0
Semantic Scholar
Microangiopathie thrombotique glomérulaire associée à une maladie de Castleman multicentrique : à propos d’un nouveau cas
Cited by 0
Semantic Scholar
Chimiothérapie de la maladie de Hodgkin
Cited by 1
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(64)
Chronic Lymphocytic Leukemia Research
(64)
Acute Myeloid Leukemia Research
(52)
Multiple Myeloma Research and Treatments
(39)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(29)
Affiliations
The University of Texas MD Anderson Cancer Center
Université de Montpellier
Sorbonne Université
Centre Hospitalier Universitaire de Montpellier
Acute Leukemia French Association